March Private Market UpdateFebruary shows slight uptick in Forge’s investor interest prior to bank turbulence
March Private Market Update
bluestargenomics.comHealthcareFounded: 2016Funding to Date: $86.62MM
Bluestar Genomics develops next-generation epigenomic approaches to detect deadly cancers, like pancreatic, early when curative therapies are possible.
View Enterprise Value for Bluestar Genomics.
